ICU Medical Inc (ICUI) stock
ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3032% above fair value
$177.30−0.96 (-0.54%)
Close on Nov 12, 2026Market cap $4.43BP/E 73.6Yield –
ICU Medical statistics
102 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 18, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 25.75
- 4.85
- P/OCF Ratio
- 15.88
- 22.12
Enterprise valuationIndustry
- EV / Sales
- 2.42
- 2.70
- EV / EBIT
- 47.75
- 24.04
- EV / FCF
- 25.33
- 27.78
Share statisticsIndustry
- Shares Change (YoY)
- 2.25%
- 3.22%
- Shares Change (QoQ)
- 0.01%
- 0.16%
- Float
- 25M
- 37M
- Shares Held by Insiders
- 1.77%
- 10.5%
- Shares Held by Institutions
- 104.2%
- 60.2%
Short sellingIndustry
- Short Interest
- 2M
- –
- Short Interest Change
- -2.39%
- -2.57%
- Short % of Float
- 6.81%
- 5.12%
- Short % of Shares Outstanding
- 6.69%
- 3.98%
- Days to Cover
- 8.02
- 3.94
Stock price statisticsIndustry
- 52-Week High
- $192.85
- –
- 52-Week Low
- $113.37
- –
- 20-Day Moving Average
- $168.11
- –
- 50-Day Moving Average
- $163.46
- –
- 200-Day Moving Average
- $149.45
- –
- Average True Range (14)
- $6.64
- –
- Price Change (1 Week)
- 5.76%
- 2.01%
- Price Change (1 Month)
- 8.98%
- -0.57%
- Price Change (3 Months)
- -3.10%
- -7.91%
- Price Change (6 Months)
- 44.2%
- -0.90%
- Price Change (YTD)
- 24.3%
- -0.82%
- Price Change (1 Year)
- 23.8%
- -1.18%
- Price Change (3 Years)
- 116.1%
- 6.56%
- Price Change (5 Years)
- -27.2%
- -49.8%
- Price Change (10 Years)
- 22.9%
- 57.3%
- Average Volume (10 Days)
- 347,043
- –
- Average Volume (20 Days)
- 278,884
- –
- Average Volume (90 Days)
- 273,863
- –
- Relative Volume
- 1.06
- 0.82
- Relative Strength Index (14)
- 60.3
- 47.7
- Volatility (1 Year)
- 35.5%
- 64.2%
- Beta (5 Years)
- 1.00
- 1.05
MarginsIndustry
- Pretax Margin
- 1.81%
- -2.55%
- EBITDA Margin
- 14.2%
- -2.82%
- FCF Margin
- 9.56%
- 0.40%
Returns on capitalIndustry
- Return on Equity (ROE)
- 2.79%
- -17.1%
- Return on Assets (ROA)
- 1.50%
- -12.2%
- Return on Invested Capital (ROIC)
- 3.58%
- -3.22%
- Return on Capital Employed (ROCE)
- 3.23%
- -8.13%
Financial positionIndustry
- Current Ratio
- 2.37
- 2.45
- Quick Ratio
- 0.99
- 1.53
- Debt / Equity
- 0.53
- 0.42
- Debt / EBITDA
- 3.71
- 2.19
- Debt / FCF
- 5.52
- 3.62
- Net Debt / EBITDA
- 2.74
- 1.53
- Interest Coverage
- 1.41
- -1.68
GrowthIndustry
- Revenue Growth (YoY)
- -5.92%
- 9.24%
- FCF Growth (YoY)
- 189.9%
- 7.64%
- Revenue Growth (3Y CAGR)
- -0.72%
- 7.08%
- Revenue Growth (5Y CAGR)
- 11.9%
- 11.8%
- EPS Growth (5Y CAGR)
- -62.5%
- 7.64%
EfficiencyIndustry
- Asset Turnover
- 0.54
- 0.59
- Inventory Turnover
- 2.12
- 2.20
- Revenue Per Employee
- $167.93K
- $330.60K
- Profits Per Employee
- $4.64K
- -$41.39K
- Employee Count
- 13,000
- 186
- WACC
- 9.24%
- 9.71%
Income statement (TTM)Industry
- Pretax Income
- $39.45M
- -$1.69M
Balance sheetIndustry
- Net Cash (Debt)
- -$850.07M
- $3.73M
- Net Cash Per Share
- -$33.99
- $0.24
- Equity (Book Value)
- $2.19B
- $63.44M
- Book Value Per Share
- $87.63
- $3.26
- Tangible Book Value
- $172.17M
- $11.04M
- Working Capital
- $705.23M
- $56.85M
Cash flow (TTM)Industry
- Capital Expenditures
- -$70.65M
- -$3.69M
- FCF Per Share
- $8.34
- -$0.01
Dividends and yieldsIndustry
- Earnings Yield
- 1.36%
- -4.70%
- FCF Yield
- 4.70%
- 0.24%
Taxes and interestIndustry
- Interest Expense
- $78.43M
- $5.33M
- Income Tax
- -$23.10M
- $1.63M
- Effective Tax Rate
- -58.6%
- 18.3%
Scores and fair valueIndustry
- Graham Number
- $68.93
- $38.11
- Graham Upside
- -61.1%
- -56.3%
- Altman Z-Score
- 2.65
- 2.44
- Piotroski F-Score
- 6
- 5
- Beneish M-Score
- -2.65
- -2.64
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | ICUI | S&P 500 | Difference | ICUI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +8.2% | -2.7% | +10.9 pts | ||
| 3 months | -1.1% | -1.7% | +0.6 pts | ||
| Year to date | +24.3% | +11.9% | +12.4 pts | ||
| 1 year | +27.4% | +12.0% | +15.4 pts | ||
| 3 years | +116.5% | +78.2% | +38.3 pts | +29.4% | +21.2% |
| 5 years | -27.2% | +73.2% | −100.5 pts | -6.2% | +11.6% |
| 10 years | +22.9% | +309.6% | −286.8 pts | +2.1% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
2M ICUI shares were sold short on Oct 30, 2026, down 2.4% from the previous report, or 6.81% of the shares available to trade. At recent volumes it would take 8.0 days to buy them back. Over the last 20 sessions, 68.8% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 1,672,002 | -2.4% | 208,522 | 8.0 |
| Oct 15, 2026 | 1,712,861 | +12.5% | 219,095 | 7.8 |
| Sep 30, 2026 | 1,523,113 | +0.5% | 280,237 | 5.4 |
| Sep 15, 2026 | 1,515,688 | +5.8% | 241,127 | 6.3 |
| Aug 31, 2026 | 1,433,092 | +3.5% | 212,627 | 6.7 |
| Aug 14, 2026 | 1,384,259 | -0.2% | 387,620 | 3.6 |
| Jul 31, 2026 | 1,387,706 | -24.3% | 284,963 | 4.9 |
| Jul 15, 2026 | 1,832,002 | +8.7% | 273,381 | 6.7 |
| Jun 30, 2026 | 1,685,563 | -4.9% | 369,104 | 4.6 |
| Jun 15, 2026 | 1,773,120 | -3.5% | 260,030 | 6.8 |
| May 29, 2026 | 1,837,896 | +12.6% | 334,937 | 5.5 |
| May 15, 2026 | 1,632,597 | +0.3% | 292,571 | 5.6 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?